Salvianolic Acid B Inhibits ERK and p38 MAPK Signaling in TGF-β1-Stimulated Human Hepatic Stellate Cell Line (LX-2) via Distinct Pathways

被引:34
作者
Lv, Zhigang [1 ,2 ,3 ]
Xu, Lieming [1 ,2 ,4 ,5 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Shanghai 201203, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Inst Liver Dis, Shanghai 201203, Peoples R China
[3] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA
[4] Shanghai Univ Tradit Chinese Med, Key Lab Liver & Kidney Dis, Minist Educ, Shanghai 200444, Peoples R China
[5] Shanghai Univ, E Inst Tradit Chinese Med Internal Med, Shanghai 201203, Peoples R China
基金
上海市自然科学基金;
关键词
ACTIVATED PROTEIN-KINASE; LIVER FIBROSIS; CROSS-TALK; SMAD; EXPRESSION; TGF-BETA-1; CYTOKINES; TARGETS; PAI-1;
D O I
10.1155/2012/960128
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Salvianolic acid B (SA-B) is water-soluble component of Radix Salvia miltiorrhiza. The previous work indicated that SA-B can inhibit MAPK and Smad signaling in activated hepatic stellate cells (HSCs) to performanti-fibrotic activity Lv et al. 2010. However, some studies have shown that there is cross-talk between MAPK and Smad in certain cell types. Thus, the anti-fibrotic action of SA-B may be through the cross-talk. In order to clarify the mechanism of SA-B further, we knocked down Smad in LX-2 cells (SRV4) via RNAi, and then added TGF-beta 1, and PD98059 or SB203580 and SA-B. The levels of p-MEK and p-p38 were inhibited by SA-B in SRV4 independent of TGF-beta 1. The expression of Col I and alpha-SMA in SRV4 could be reduced by SA-B independent TGF-beta 1. SB203580 had not significant effect on p-MEK in SRV4 stimulated by TGF-beta 1. The levels of p-MEK in SRV4 were not increased significantly after TGF-beta 1 stimulation. PD98059 had no effect on the levels of p-p38 in SRV4 irrespective of TGF-beta 1. In conclusion, SA-B inhibits the synthesis of Col I in LX-2 cells independent of TGF-beta 1 stimulation, and the anti-fibrotic effect of SA-B is due to direct inhibition of p38 signaling and inhibition the cross-talk of Smad to ERK signaling.
引用
收藏
页数:11
相关论文
共 23 条
  • [1] TGF-β1 targets the GSK-3β/β-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts
    Caraci, Filippo
    Gili, Elisa
    Calafiore, Marco
    Failla, Marco
    La Rosa, Cristina
    Crimi, Nunzio
    Sortino, Maria Angela
    Nicoletti, Ferdinando
    Copani, Agata
    Vancheri, Carlo
    [J]. PHARMACOLOGICAL RESEARCH, 2008, 57 (04) : 274 - 282
  • [2] The role of TGF-β1 and cytokines in the modulation of liver fibrosis by Sho-saiko-to in rat's bile duct ligated model
    Chen, MH
    Chen, JC
    Tsai, CC
    Wang, WC
    Chang, DC
    Tu, DG
    Hsieh, HY
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2005, 97 (01) : 7 - 13
  • [3] Liver fibrosis: from mechanisms to treatment
    Friedman, Scott L.
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2007, 31 (10): : 812 - 814
  • [4] Human and rat hepatic stellate cells produce stem cell factor:: a possible mechanism for mast cell recruitment in liver fibrosis
    Gaça, MDA
    Pickering, JA
    Arthur, MJP
    Benyon, RC
    [J]. JOURNAL OF HEPATOLOGY, 1999, 30 (05) : 850 - 858
  • [5] Cross-talk between ERK MAP kinase and Smad-signaling pathways enhances TGF-β dependent responses in human mesangial cells
    Hayashida, T
    deCaestecker, M
    Schnaper, HW
    [J]. FASEB JOURNAL, 2003, 17 (09) : 1576 - +
  • [6] ERK contributes to the effects of Smad signaling on oxidized LDL-induced PAI-1 expression in human mesangial cells
    Hong, Hye Kyoung
    Song, Chi Young
    Kim, Bong Cho
    Lee, Hyun Soon
    [J]. TRANSLATIONAL RESEARCH, 2006, 148 (04) : 171 - 179
  • [7] Hu YY, 1997, ACTA PHARMACOL SIN, V18, P478
  • [8] TGF-β1 in liver fibrosis:: an inducible transgenic mouse model to study liver fibrogenesis
    Kanzler, S
    Lohse, AW
    Keil, A
    Henninger, J
    Dienes, HP
    Schirmacher, P
    Rose-John, S
    Zum Büschenfelde, KHM
    Blessing, M
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1999, 276 (04): : G1059 - G1068
  • [9] p38 map kinases: Key signalling molecules as therapeutic targets for inflammatory diseases
    Kumar, S
    Boehm, J
    Lee, JC
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (09) : 717 - 726
  • [10] Liu Chenghai, 2002, Zhonghua Yi Xue Za Zhi, V82, P1267